Upadacitinib Hemihydrate

ATC — · 4 markets · 11 records

Upadacitinib Hemihydrate 4 markets · 11 records Forms

AU 4 records · 4 strengths

46.1 mgtablet · extended-releaseRINVOQ upadacitinib 15 mg modified release tablet blister pack unknown
30.7 mgtablet · extended-releaseRINVOQ upadacitinib 15 mg modified release tablet blister pack unknown
15.4 mgtablet · extended-releaseRINVOQ upadacitinib 15 mg modified release tablet blister pack unknown

Records without a stated strength · 1 Rinvoq

SG 3 records · 3 strengths

45 mgtablet · extended-releaseRINVOQ Extended-Release Tablets 45 mg also in TW
30 mgtablet · extended-releaseRINVOQ Extended-Release Tablets 45 mg also in TW
15 mgtablet · extended-releaseRINVOQ Extended-Release Tablets 45 mg also in TW

TW 3 records · 3 strengths

45 mgtablet · extended-releaseRINVOQ Extended-Release Tablets 45 mg+1銳虎持續性藥效錠45毫克 also in SG
30 mgtablet · extended-releaseRINVOQ Extended-Release Tablets 45 mg+1銳虎持續性藥效錠30毫克 also in SG
15 mgtablet · extended-releaseRINVOQ Extended-Release Tablets 45 mg+1銳虎持續性藥效錠15毫克 also in SG

GB 1 records · 1 strengths

15 mgtabletRinvoq 15mg modified-release tablets

The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.

A side-by-side table is offered only when this ingredient has records in many markets; otherwise this list is the whole picture.